🩺 Clinical case preview - tonight’s #EASLMTB! A 75-year-old male with HCV-related cirrhosis and a new 57 mm sVIII nodule with vascular invasion. 👉 Diagnosis: hepatocellular carcinoma. How will he respond to treatment? What will happen next? 🚨 Register and join the experts' discussion in 30 minutes! easl-eu.zoom.us/webinar/regi… @EASLnews @MarcoSanduzzi @VChernyakMD @siadaniela @Vaital73 #EASLMTB #LiverX

🧬And what about the molecular perspective? How does tumour biology shape treatment decisions? @siadaniela: 🔬 Biopsy and molecular testing can help target new cells and reverse resistance. @EASLnews @ma5RN @MarcoSanduzzi @VChernyakMD @Vaital73 #EASLMTB #LiverX

Thank you to our amazing panel! 🙏✨ @ma5RN @MarcoSanduzzi @VChernyakMD @siadaniela @Vaital73 Join us next January in Edinburgh for an in-person #EASLMTB episode at the EASL Liver Cancer Summit 2026: 📅 Friday, 23 January 2026 | 10:05 CET 🔗 Event link: pag.virtual-meeting.org/easl… 👉 EASL LCS 2026 registration link: easl.eu/event/liver-cancer-s… @EASLnews #LiverX

Concordance of ctDNA and tissue genomic profiling in biliary tract cancer @JHepatology doi.org/10.1016/j.jhep.2024.… 👉concordance in 84.8%, 👉ctDNA revealed 🎯GA in 34.3% 👉high VAF in ctDNA associated w/ poor prognosis 🧐LB valuable option @myESMO @EASLedu @ILCAnews @curecc #livertwitter

Our review on "Morphomolecular pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and combined Hepatocellular-Cholangiocarcinoma" was recently released in Am J Pathol @siadaniela ajp.amjpathol.org/article/S0…

Fantastic roundtable discussions with the experts & Young Investigators! #ILCA2024 @Valeriechew29 @siadaniela @chiarabraconi @graokane @ILCAnews. Look forward to the YI masterclass today on social media & science 🧬👩‍💻@CappuynsSarah @A_DAlessioMD

What a start for #ILCA24 ! Enthusiastic participation to the roundtables organised by the Young ILCA committee - so enlightening to hear the career development advice of our stellar speakers! @marinabaretti @graokane @chiarabraconi @Valeriechew29 @ILCAnews

Why we do what we do @ILCAnews ➡️power of the patient voice from the wonderful @melinda_bachini 💕pay it forward💕 ➡️need drug & clinical trial access ➡️PROs in studies ➡️more practical trial design @curecc @UCDCancerTrials @cancertrials_ie #ILCA24

Struggling to balance your research with the fast-paced world of social media? You're not alone. Join Sarah Cappuyns at #ILCA24 for our dedicated session to learn the advantages and challenges of using social media in your scientific research. 👀 ilcalive.org/annual-conferen…

On June 1, 2024, we proudly joined the Liver Life Walk NYC with 34 teams and 294 walkers. Huge thanks to Dr. Douglas Dieterich, this year's Medical Chair. Grateful to everyone who participated and supported us. #LiverLifeWalk #Gratitude #ALF @DOMSinaiNYC @liverUSA

Proud of this amazing scientist @emilybramel and thankful to the @curecc for another wonderful annual conference!!

Grateful to the scientific community, @staclinds, Juan Valle, and a wonderful co-chair @siadaniela for making the first Basic Science Track at @curecc Annual Conference a huge success. We had remarkable speakers from all over the world in a packed room with robust discussion.

The Genetic and Epigenetic Drivers of CCA session at @curecc was a great session with a lively discussion covering: 👉🏼 cancer epigenomics at the single cell level 👉🏼 germine genetics and CCA risk 👉🏼 genetics of CCA subtypes 👉🏼 tumor genotype-immune phenotype relationship

We are looking for a post-doctoral fellow to join our research group at Mount Sinai in New York City. Required experience with mice, friendly and teamworker. To apply: nature.com/naturecareers/job…

Seeking a motivated post-doc to study novel mouse models of cholangiocarcinoma with KRASG12D mutations. Help us explore how KRAS impacts the immune response and therapy outcomes. Apply now: bit.ly/3vG5zg6 #CancerResearch #PostDocJobs #NYC #WeFindAWay @DOMSinaiNYC

Today is World Cholangiocarcinoma Day! #WorldCCADay. Please join us in spreading awareness of CCA and sign the pledge. It's time to #BeClearOnCCA.

#EASLStudio: 👉Check regularly the treatment response 👉 Immune check point inhibitors ➡️ have limited effect alone 👉 Do biopsy as much as possible 👉 Molecular profiling (DNA RNA seq) for fusion & liquid biopsy for mutation identification 🧐 % of 5-yrs survival remains low

📢 Don't forget to tune today @ 18:00 CET for the #EASLStudio scheduled in honour of the #WorldCCADay! 📺easl.eu/easl-studio-episode/… 🗣️@ThomasBerg24, Katie Kelley, @siadaniela & Juan Valle #livertwitter @EASLnews

Second annual Liver Cancer Shark Tank was once again standing room only. Congrats to all the presenters on the great pitches and to the winner @AndrewMMoon! Was fun to be a shark. #TLM2023 @docamitgs @davidepovero @NDP1001 @siadaniela